Avenue Therapeutics
may have a more tolerable side effect profile compared to nonselective due to greater subtype selectively | Avenue Therapeutics
Company
Deck Type
IPO
Sector
Industry
Deck date
October 2022
Slide
10 of 30
Related slides by other companies
Ocuphire Pharma
Results
March 2022
product candidate profile on | Ocuphire Pharma
Ocuphire Pharma
Investor Day
January 2022
product candidate profile for multiple retinal indications | Ocuphire Pharma
Ocuphire Pharma
Investor Day
January 2022
product candidate profile on | Ocuphire Pharma
Informa
Investor Day
December 2021
in depth company profile amplifies lifetime value | Informa
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights